Expiration date for a 6% solution of albumin made from a commercially prepared 22% solution of albumin
A transfusion service lead technologist located
in Nevada asks if colleagues
would comment upon what they use as an expiration date for a 6% solution
of albumin made from a commercially prepared 22% solution of albumin,
when the 22% albumin has been diluted with 0.8% saline. She states that
Method 1.5 on pages 726 and 727 of the 15th edition of the AABB Technical
Manual discusses the procedure to accomplish this dilution, but gives
no guidance as to the expiration date of the newly prepared diluted solution.
Furthermore, the cited references for this method (on page 728) are quite
old. She acknowledges not having checked these references to determine
if an expiration recommendation is given. She attempted to contact
the manufacturer of the 22% albumin to ascertain if they can be of help in
this matter, but they merely told her to check the old references given
in the Technical Manualor to perform
an in-house validation of the diluted
product. However, the inquiring colleague points out that since this diluted
product is utilized as a negative control, she is not certain how
she can determine if it is performing as expected, given no visible cloudiness
or contamination are observed? In the meantime, she is interested in input
from other blood bank professionals.
The following comments have been received.
ADDENDA October 2, 2007
- A colleague affiliated with
an immunohematology reference laboratory reports that it is important to check the reagent manufacturer's instructions
as some have a statement regarding not diluting their
reagent. So assuming
that the manufacturer is silent about dilution, then the lab can proceed.
The best choice is to validate newly prepared reagent
versus stored reagent using boundary testing scenarios. If the laboratory has not "validated" the
storage time and determines it cannot, then reasonable choices should
be made. Assignment of expiration date could be based
on historical information (retrospective review) that there were no adverse impacts of storage of
the solution in a variety of cases. It is impossible to be able to give
a standard time without knowledge of the use and storage parameters of
the reagent. It is also important to have the practice
and validation process approved by the facility's Quality Assurance Unit (or its equivalent).
ADDENDA October 4, 2007
- A colleague who works in an
Immunohematology Reference Laboratory located in Southern
California reports that they prepare 6%
and 10% albumin from commercial sources of albumin (22%
is now all that is available) using a method similar to that cited from
the Technical Manual. They use a 6-month
expiration date because that
has worked successfully for them for many years, but they
occasionally use up the preparation before 6 months has elapsed. Like
the manufacturer recommends, each lab would have to determine by day-of-use
QC whether the in-house preparation is working as expected
up to the projected expiration date. The obvious risk
in this instance is contamination of the reagent, so her advice would be to prepare
an amount that would last a few months and aliquot it into smaller vials so that if one vial got contaminated, another vial would be available
to use if additional reagent needed to be prepared. As for the comment
regarding manufacturer’s
directions not to dilute the reagent, they asked
an FDA representative (speaker at a conference) about this exact situation.
Her response was that the manufacturer’s warning applied to use
of that reagent for the purpose of antibody enhancement (e.g., antibody
screening or identification) but that if the 22%
albumin were just being used as a source of albumin for
a totally different purpose, the manufacturer’s
warning did not apply.
- An immunohematology specialist
and an associate editor of the 16th edition of the AABB Technical
Manual reports
that at her hospital, they use a commercially prepared
saline that has
an expiration of 30 days from the date of opening.
When preparing reagents using this saline they assign an outdate
based on the shortest outdate of all the components; this usually
ends up being the outdate of the saline. When saline
prepared in-house is used and the albumin has an outdate
12 or more months in the future, using the outdate of
the albumin may not be appropriate. In this situation, validation
should be done for a reasonable outdate such as 1-3 months.
Although this reagent is used as a negative control,
validation of expected
negative results and lack of visible contamination can
be performed. Finally, she points out to the colleague
who initiated this discussion that in the 15th edition
of the AABB Technical Manual, there are no
references associated with Method 1.5 Dilution of % Solutions.
The cited
references on page 728
are with Method 1.7 Preparation and Use of Phosphate Buffer.
ADDENDA Oct. 23, 2007
- A technical supervisor at
a transfusion service in an Arizona hospital reports
that they prepare 6% albumin by combining 36.6 ml of normal
saline with 10 ml
of 22% albumin. They label the diluted reagent with "No
Expiration Date" and
use the 6% albumin as long as 'QC' is acceptable. The QC
consists of testing
the 6% albumin against a reagent red cell used for patient
testing to obtain
an expected negative result. She comments that colleagues
who impose a 30 day
expiration for diluted albumin reagent seem to be doing
so based on the
expiration of room temperature stored saline used in the
dilution step.
Since the Arizona colleague's lab stores their 6%
albumin at refrigerator
temperature, they do not believe that a 30 day expiration
is applicable.
Finally, it has been their experience that by preparing
10 ml of 6% albumin at
a time, they use up the reagent before any contaminant
has a chance to grow.
- Editors' note: The current
CAP transfusion medicine checklist (available online from CAP.org) includes Phase II item TRM.31220: Are reagents
and solutions
properly labeled, as applicable and appropriate, with the
following
elements?
- Content and quantity, concentration or titer
- Storage requirements
- Date prepared or reconstituted by laboratory
- Expiration date
- Lot number, as applicable
The previous e-Network Forum discussion "What
are the QC requirements for isotonic saline used with automatic
cell washers?"
may be
germane to this topic.
- Editors' note: 42
CFR 493.1252(b) appears to be germane to this topic and
is reproduced below:
The laboratory must define criteria for those conditions that
are essential for proper storage of reagents and specimens,
accurate and
reliable test system operation, and test result reporting.
The criteria
must be consistent with the manufacturer's instructions,
if provided. These conditions must be
monitored and documented and, if applicable,
include the following:
(1) Water quality.
(2) Temperature.
(3) Humidity.
(4) Protection of equipment and instruments from fluctuations
and
interruptions in electrical current that adversely affect
patient test
results and test reports.
(c) Reagents, solutions, culture
media, control materials, calibration materials, and other
supplies, as appropriate, must be
labeled to indicate the following:
(1) Identity and when
significant, titer, strength or concentration.
(2) Storage requirements.
(3) Preparation and expiration dates.
(4) Other pertinent information required for proper use.
(d) Reagents, solutions, culture media,
control materials, calibration materials, and other supplies
must not be used when they
have exceeded their expiration date, have deteriorated,
or are of
substandard quality.
(e) Components of reagent kits of different lot numbers
must not be
interchanged unless otherwise specified by the manufacturer.
Submit comments to the e-Network Forum at enetworkforum@cbbsweb.org
Ira A. Shulman, MD
CBBS e-Network Forum Senior Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Editor & Moderator
Elizabeth M. St. Lezin, MD
CBBS e-Network Forum Associate Editor & Moderator
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.